Attitudes towards pharmaceutical companies in the UK
Welcome to the UK Pharma Reputation Index. This site covers the latest research from the ABPI-Ipsos Attitudes towards pharmaceutical companies in the UK study. Read further to find out more about the reputation of pharmaceutical companies operating in the UK.
About this study
This study outlines some of the headlines and key insights from three years of research with the public and healthcare professionals to find out what they know, think and feel about pharmaceutical companies in the UK – and how this has changed over time.
Our index combines ongoing qualitative and quantitative research with in-depth analysis to bring you a snapshot of the industry’s reputation. Whether you’re interested in what the general public and other stakeholders understand about the sector or their views on granular issues around transparency, access to medicines, innovation and patient focus and more, you will find useful insights here.
Reputation snapshot
The new data from 2025 shows perceptions of the pharmaceutical industry remain largely consistent with previous years. Familiar assumptions, both positive and negative, for example about the industry’s research and development (R&D) efforts and medicine pricing, continue to shape views of the sector.
General Public
The findings suggest that while the industry’s reputation is stable, there is no room for complacency.
There are important areas where more effective communication and engagement can help build deeper trust.
Healthcare Professionals
Healthcare professionals (HCPs) are often closer to the pharmaceutical industry than the other audiences in this study. Here, we explore what they think of the sector, how they rate their interactions with it and how their views have evolved.
General Public
Using data collected since 2020, we’ve analysed how the sector’s response to COVID shaped public opinion and what this might mean for the sector’s reputation in the longer term.
HCPs
We’ve asked a range of HCPs what they think about the sector’s response to the pandemic and assessed the extent to which this is shaping their perceptions of the sector.
Research Methods
We used different research methodologies to provide a comprehensive snapshot of the industry’s reputation. Click on the link below to find more details.
Contact
Us
Thomas Fife-Schaw
Research Director
Ipsos MORI
Thomas.Fife-Schaw@ipsos.com
Jill Pearcy
Director Reputation
ABPI
JPearcy@abpi.org.uk